{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:34:14Z","timestamp":1793090054296,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Higher Education and Scientific Research of Tunisia"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.molimm.2013.08.009","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T12:00:28Z","timestamp":1380628828000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency"],"prefix":"10.1016","volume":"57","author":[{"given":"Im\u00e8ne","family":"Turki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akil","family":"Hammami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Kharmachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Mousli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2013.08.009_bib0005","first-page":"652147","article-title":"Generation and characterization of an scFv directed against site II of rabies glycoprotein","author":"Aavula","year":"2011","journal-title":"Biotechnol. Res. Int."},{"key":"10.1016\/j.molimm.2013.08.009_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1742-4658.2011.08417.x","article-title":"Construction and humanization of a functional bispecific EGFR\u00d7CD16 diabody using a refolding system","volume":"279","author":"Asano","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.molimm.2013.08.009_bib0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0958-1669(02)00352-X","article-title":"Pharmacokinetics and biodistribution of genetically engineered antibodies","volume":"13","author":"Batra","year":"2002","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0020","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.vaccine.2013.01.025","article-title":"Monoclonal antibodies for prophylactic and therapeutic use against viral infections","volume":"31","author":"Both","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2013.08.009_bib0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/BF01314961","article-title":"The glycoprotein G of rhabdoviruses","volume":"140","author":"Coll","year":"1995","journal-title":"Arch. Virol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/JVI.72.1.273-278.1998","article-title":"An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro","volume":"72","author":"Coulon","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0035","doi-asserted-by":"crossref","first-page":"e5381","DOI":"10.1371\/journal.pone.0005381","article-title":"In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences","volume":"4","author":"Cuesta","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2013.08.009_bib0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.molimm.2012.03.015","article-title":"A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency","volume":"51","author":"Duan","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/mabs.20776","article-title":"Molecular engineering of antibodies for therapeutic and diagnostic purposes","volume":"4","author":"Ducancel","year":"2012","journal-title":"MAbs"},{"key":"10.1016\/j.molimm.2013.08.009_bib0050","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1096\/fj.08-111484","article-title":"Production of multivalent protein binders using a self-trimerizing collagen-like peptide scaffold","volume":"22","author":"Fan","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.molimm.2013.08.009_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jchromb.2008.10.030","article-title":"Chromatographic purification of equine immunoglobulin G F(ab)2 from plasma","volume":"876","author":"Fernandes","year":"2008","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.molimm.2013.08.009_bib0060","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2013.057","article-title":"Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies","volume":"8","author":"Fields","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molimm.2013.08.009_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0092-1157(79)80038-4","article-title":"A collaborative study on the testing of rabies immune globulin (human) by the mouse neutralization test (MNT) and the rapid fluorescent focus inhibition test (RFFIT)","volume":"7","author":"Fitzgerald","year":"1979","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.molimm.2013.08.009_bib0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-1759(85)90044-4","article-title":"Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay","volume":"77","author":"Friguet","year":"1985","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2013.08.009_bib0075","series-title":"Gel Electrophoresis of Proteins: A Practical Approach","author":"Hames","year":"1990"},{"key":"10.1016\/j.molimm.2013.08.009_bib0080","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0085","first-page":"3055","article-title":"Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts","volume":"56","author":"Hu","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.molimm.2013.08.009_bib0090","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00253-011-3168-8","article-title":"Trimerization of murine TNF ligand family member LIGHT increases the cytotoxic activity against the FM3A mammary carcinoma cell line","volume":"90","author":"Ito","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0022-1759(87)90170-0","article-title":"Human monoclonal antibody production: current status and future prospects","volume":"100","author":"James","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2013.08.009_bib0100","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.molimm.2013.08.009_bib0105","first-page":"817","article-title":"The carboxy-terminal domain initiates trimerization of bacteriophage T4 fibritin","volume":"64","author":"Letarov","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.molimm.2013.08.009_bib0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s002620000115","article-title":"Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth","volume":"49","author":"Li","year":"2000","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.molimm.2013.08.009_bib0115","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1016\/j.vaccine.2004.11.071","article-title":"Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli","volume":"23","author":"Motoi","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2013.08.009_bib0120","first-page":"473","article-title":"Genetically engineered colorimetric single-chain antibody fusion protein for rapid diagnosis of rabies virus","volume":"131","author":"Mousli","year":"2008","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.molimm.2013.08.009_bib0125","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jviromet.2007.07.015","article-title":"Recombinant single-chain Fv antibody fragment\u2013alkaline phosphatase conjugate: a novel in vitro tool to estimate rabies viral glycoprotein antigen in vaccine manufacture","volume":"146","author":"Mousli","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.molimm.2013.08.009_bib0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0166-0934(97)00099-2","article-title":"Phage-displayed and soluble mouse scFv fragments neutralize rabies virus","volume":"67","author":"Muller","year":"1997","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.molimm.2013.08.009_bib0135","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1111\/j.1742-4658.2009.07129.x","article-title":"Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro","volume":"276","author":"Muzard","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.molimm.2013.08.009_bib0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2012.08.003","article-title":"High level prokaryotic expression of anti-M\u00fcllerian inhibiting substance type II receptor diabody, a new recombinant antibody for in vivo ovarian cancer imaging","volume":"387","author":"Ortega","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2013.08.009_bib0145","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1074\/jbc.M311791200","article-title":"Formation of highly stable chimeric trimers by fusion of an adenovirus fiber shaft fragment with the foldon domain of bacteriophage T4 fibritin","volume":"279","author":"Papanikolopoulou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2013.08.009_bib0150","series-title":"Laboratory Techniques in Rabies","first-page":"433","article-title":"Techniques for the preparation of rabies conjugates","author":"Perrin","year":"1996"},{"key":"10.1016\/j.molimm.2013.08.009_bib0155","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1006\/viro.1995.1356","article-title":"Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing","volume":"210","author":"Raux","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.molimm.2013.08.009_bib0160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1365-2249.2001.01515.x","article-title":"Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1","volume":"125","author":"Ray","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0165","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Clinical practice. Prophylaxis against rabies","volume":"351","author":"Rupprecht","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2013.08.009_bib0170","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ijc.21851","article-title":"Enhanced antiangiogenic therapy with antibody-collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events","volume":"119","author":"S\u00e1nchez-Ar\u00e9valo Lobo","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molimm.2013.08.009_bib0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.it.2003.12.001","article-title":"Antibodies and gene therapy: teaching old \u2018magic bullets\u2019 new tricks","volume":"25","author":"Sanz","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0180","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.2741\/3024","article-title":"Production systems for recombinant antibodies","volume":"13","author":"Schirrmann","year":"2008","journal-title":"Front Biosci."},{"key":"10.1016\/j.molimm.2013.08.009_bib0185","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.4049\/jimmunol.135.2.1530","article-title":"Human immune response to multiple injections of murine monoclonal IgG","volume":"135","author":"Shawler","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0190","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/vir.0.81063-0","article-title":"Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor","volume":"86","author":"Sisso\u00ebff","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0195","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1126\/science.3285470","article-title":"Assembly of a functional immunoglobulin Fv fragment in Escherichia coli","volume":"240","author":"Skerra","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.molimm.2013.08.009_bib0200","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0969-2126(97)00233-5","article-title":"Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain","volume":"5","author":"Tao","year":"1997","journal-title":"Structure"},{"key":"10.1016\/j.molimm.2013.08.009_bib0205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.nbt.2009.07.005","article-title":"Multimerization domains for antibody phage display and antibody production","volume":"26","author":"Thie","year":"2009","journal-title":"New Biotechnol."},{"key":"10.1016\/j.molimm.2013.08.009_bib0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-1759(00)00342-2","article-title":"Design and application of diabodies, triabodies and tetrabodies for cancer targeting","volume":"248","author":"Todorovska","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2013.08.009_bib0215","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/BJ20081449","article-title":"The C-terminus of the P22 tailspike protein acts as an independent oligomerization domain for monomeric proteins","volume":"419","author":"Webber","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.molimm.2013.08.009_bib0220","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.biotechadv.2009.04.004","article-title":"Applications of single-chain variable fragment antibodies in therapeutics and diagnostics","volume":"27","author":"Weisser","year":"2009","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.molimm.2013.08.009_bib0225","series-title":"Laboratory Techniques in Rabies","author":"WHO (World Health Organization)","year":"1996"},{"key":"10.1016\/j.molimm.2013.08.009_bib0230","series-title":"World Health Organization Expert Consultation on Rabies, Eighth Report, WHO Technical Report Ser. 824","author":"WHO (World Health Organization)","year":"1992"},{"key":"10.1016\/j.molimm.2013.08.009_bib0235","series-title":"Expert Consultation on Rabies, First Report, WHO Technical Report Ser. 931","author":"WHO (World Health Organization)","year":"2005"},{"key":"10.1016\/j.molimm.2013.08.009_bib0240","first-page":"5758","article-title":"High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment","volume":"59","author":"Willuda","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.molimm.2013.08.009_bib0245","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/JVI.76.9.4634-4642.2002","article-title":"Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin","volume":"76","author":"Yang","year":"2002","journal-title":"J. Virol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589013004914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589013004914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T23:44:10Z","timestamp":1688514250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589013004914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0161589013004914"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2013.08.009","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2013.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}